Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zomedica Corp.ZOM · Entity 6884 | President & CMO | April 12, 2021 | April 13, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zomedica Corp.
Report date April 12, 2021 · Filed April 13, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, without par valueSEC Table I · non-derivative | Direct | 1,459,580 |
Ending reported balance
After 2021-04-12 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2021-04-12 · Exercise / conversion · Acquired 305,000 · Balance 1,764,580 Row 2 · 2021-04-12 · Sale · Disposed 305,000 · Balance 1,459,580 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2021. Row 3 · 2021-04-12 · Exercise / conversion · Acquired 500,000 · Balance 1,959,580 Row 4 · 2021-04-12 · Sale · Disposed 500,000 · Balance 1,459,580 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2021. |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.19 · Expires 2025-03-14 | Direct | 445,000 |
Reported balance
After 2021-04-12 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2021-04-12 · Exercise / conversion · Disposed 305,000 · Balance 445,000 F2: The option vests in 4 equal annual installments commencing March 13, 2020. |
| Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.43 · Expires 2021-09-16 | Direct | 0 |
Reported balance
After 2021-04-12 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2021-04-12 · Exercise / conversion · Disposed 500,000 · Balance 0 |
| Common Stock, without par valueSEC Table I · non-derivative | IndirectBy daughter | 1,000 |
Reported balance
Holding disclosure · report date 2021-04-12 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 1,000 |
| Common Stock, without par valueSEC Table I · non-derivative | IndirectBy daughter | 1,000 |
Reported balance
Holding disclosure · report date 2021-04-12 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 1,000 |
| Common Stock, without par valueSEC Table I · non-derivative | IndirectBy step-daughter | 1,000 |
Reported balance
Holding disclosure · report date 2021-04-12 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 1,000 |
| Common Stock, without par valueSEC Table I · non-derivative | IndirectBy step-son | 1,000 |
Reported balance
Holding disclosure · report date 2021-04-12 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 1,000 |
| Common Stock, without par valueSEC Table I · non-derivative | IndirectBy step-son | 1,000 |
Reported balance
Holding disclosure · report date 2021-04-12 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 1,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2021.
F2: The option vests in 4 equal annual installments commencing March 13, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 12, 2021 Filed Apr 13, 2021 15:33 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock option (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.43 | $0.00 |
DisclosureSEC source: 0001171843-21-002446 · ownership.xml · derivative · entry 11 Morley Stephanie · CIK 0001721793 · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, without par value · 500,000 shares Expires 2021-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 15:33 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock option (right to buy) · Derivative | 305,000 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001171843-21-002446 · ownership.xml · derivative · entry 10 Morley Stephanie · CIK 0001721793 · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,000 Underlying: Common Stock, without par value · 305,000 shares Expires 2025-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in 4 equal annual installments commencing March 13, 2020. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 15:33 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Stock, without par value | 500,000 | $1.16 | $578,350.00 |
DisclosureSEC source: 0001171843-21-002446 · ownership.xml · nonDerivative · entry 4 Morley Stephanie · CIK 0001721793 · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,459,580 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2021. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 15:33 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Stock, without par value | 500,000 | $0.43 | $215,000.00 |
DisclosureSEC source: 0001171843-21-002446 · ownership.xml · nonDerivative · entry 3 Morley Stephanie · CIK 0001721793 · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,959,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 15:33 UTC | Zomedica Corp. ZOM · Entity 6884 | SaleCommon Stock, without par value | 305,000 | $1.16 | $352,793.50 |
DisclosureSEC source: 0001171843-21-002446 · ownership.xml · nonDerivative · entry 2 Morley Stephanie · CIK 0001721793 · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,459,580 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2021. Read SEC document |
| April 12, 2021 Filed Apr 13, 2021 15:33 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Stock, without par value | 305,000 | $0.19 | $57,950.00 |
DisclosureSEC source: 0001171843-21-002446 · ownership.xml · nonDerivative · entry 1 Morley Stephanie · CIK 0001721793 · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,764,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 21:10 UTC Amendment | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 2,500,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001171843-21-000081 · ownership.xml · derivative · entry 1 Morley Stephanie · CIK 0001721793 · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500,000 Underlying: Common Shares, without par value · 2,500,000 shares Expires 2030-12-30 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing December 30, 2021. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 21:11 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 2,500,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001171843-21-000027 · ownership.xml · derivative · entry 1 Morley Stephanie · CIK 0001721793 · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500,000 Underlying: Common Shares, without par value · 2,500,000 shares Expires 2030-12-30 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing December 30, 2021. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 20:13 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 750,000 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001171843-20-001790 · ownership.xml · derivative · entry 1 Morley Stephanie · CIK 0001721793 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Shares, without par value · 750,000 shares Expires 2025-03-13 F1 · derivative.exercise_date: The option vests in 4 equal annual installments commencing March 13, 2020. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 20:02 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.43 | $0.00 |
DisclosureSEC source: 0001171843-19-005969 · ownership.xml · derivative · entry 1 Morley Stephanie · CIK 0001721793 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Shares, without par value · 500,000 shares Expires 2021-09-16 F1 · derivative.exercise_date: The options vested upon grant and are currently fully vested. Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 21:10 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Option (right to buy) · Derivative | 900,000 | $0.00 Strike: $1.52 | $0.00 |
DisclosureSEC source: 0001171843-19-000260 · ownership.xml · derivative · entry 1 Morley Stephanie · CIK 0001721793 · COO & VP of Product Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900,000 Underlying: Common Shares, without par value · 900,000 shares Expires 2021-01-10 F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 22:36 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock Option (right to buy) · Derivative | 104,000 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000403 · zomedica_form4apr202018.xml · derivative · entry 7 Morley Stephanie · CIK 0001721793 · COO & VP of Product Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 104,000 shares Expires 2018-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2018 Filed Apr 24, 2018 22:36 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Shares, without par value | 104,000 | $0.20 | $20,800.00 |
DisclosureSEC source: 0000905718-18-000403 · zomedica_form4apr202018.xml · nonDerivative · entry 1 Morley Stephanie · CIK 0001721793 · COO & VP of Product Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,459,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2018 Filed Mar 30, 2018 20:08 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000355 · zomedica_form4mar292018.xml · derivative · entry 7 Morley Stephanie · CIK 0001721793 · COO & VP of Product Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Shares, without par value · 500,000 shares Expires 2018-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| March 29, 2018 Filed Mar 30, 2018 20:08 UTC | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Shares, without par value | 500,000 | $0.20 | $100,000.00 |
DisclosureSEC source: 0000905718-18-000355 · zomedica_form4mar292018.xml · nonDerivative · entry 1 Morley Stephanie · CIK 0001721793 · COO & VP of Product Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,355,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2018 Filed Apr 17, 2018 21:08 UTC Amendment | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0000905718-18-000399 · zomedica_form4ammar302018.xml · derivative · entry 2 Morley Stephanie · CIK 0001721793 · COO & VP of Product Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares, without par value · 500,000 shares Expires 2019-08-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This amendment is being filed to correctly state the stock options that were exercised. The options that were exercised were misstated on Stephanie Morley's ("Reporting Person") original Form 4 filed with the Securities Exchange Commission on March 30, 2018. Reporting Person exercised 500,000 options at an exercise price of $2.20 per share. Reporting Person continues to hold 1,100,000 options exercisable at $0.20 per share which were granted on March 28, 2016. F2 · derivative.exercise_date: The options vested upon grant. The option is currently fully vested. Read SEC document |
| March 29, 2018 Filed Apr 17, 2018 21:08 UTC Amendment | Zomedica Corp. ZOM · Entity 6884 | Exercise / conversionCommon Shares, without par value | 500,000 | $2.20 | $1,100,000.00 |
DisclosureSEC source: 0000905718-18-000399 · zomedica_form4ammar302018.xml · nonDerivative · entry 1 Morley Stephanie · CIK 0001721793 · COO & VP of Product Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,355,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This amendment is being filed to correctly state the stock options that were exercised. The options that were exercised were misstated on Stephanie Morley's ("Reporting Person") original Form 4 filed with the Securities Exchange Commission on March 30, 2018. Reporting Person exercised 500,000 options at an exercise price of $2.20 per share. Reporting Person continues to hold 1,100,000 options exercisable at $0.20 per share which were granted on March 28, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.